4//SEC Filing
Mattessich Antony C. 4
Accession 0001104659-23-009410
CIK 0001393434other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 7:32 PM ET
Size
7.8 KB
Accession
0001104659-23-009410
Insider Transaction Report
Form 4
Mattessich Antony C.
DirectorPresident and C.E.O.
Transactions
- Award
Common Stock
2023-01-30+176,300→ 465,950 total - Award
Stock Option (Right to Buy)
2023-01-30+536,900→ 536,900 totalExercise: $3.88Exp: 2033-01-29→ Common Stock (536,900 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Includes 363,050 shares of common stock of the Company underlying unvested RSUs.
- [F3]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0001709900
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 7:32 PM ET
- Size
- 7.8 KB